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Abstract
Background: Recent studies have demonstrated an association between short-term elevations in air pollution and
an increased risk of exacerbating gastrointestinal disease. The objective of the study was to evaluate if day-to-day
increases in air pollution concentrations were positively associated with upper gastrointestinal bleeding (UGIB)
secondary to peptic ulcer disease (PUD).
Methods: A time-stratified case-crossover study design was used. Adults presenting to hospitals with their first
UGIB secondary to PUD from 2004–2010 were identified using administrative databases from Calgary (n = 1374;
discovery cohort) and Edmonton (n = 1159; replication cohort). Daily concentrations of ozone, nitrogen dioxide,
sulfur dioxide, carbon monoxide, and particulate matter (PM10 and PM2.5) were estimated in these two cities.
Conditional logistic regression models were employed, adjusting for temperature and humidity. Odds ratios (OR)
with 95 % confidence intervals (CI) were expressed relative to an interquartile range increase in the concentration
of each pollutant.
Results: No statistically significant associations were observed for any of the individual pollutants based on same-day, or
1-day lag effects within the Calgary discovery cohort. When the air pollution exposures were assessed as 3-, 5-, and 7-day
averages, some pollutants were inversely associated with UGIB in the discovery cohort; for example, 5-day averages of
nitrogen dioxide (OR = 0.68; 95 % CI: 0.53–0.88), and particulate matter <2.5 μm (OR = 0.75; 95 % CI: 0.61–0.90). However,
these findings could not be reproduced in the replication cohort.
Conclusion: Our findings suggest that short-term elevations in the level of ambient air pollutants does not increase the
incidence of UGIB secondary to PUD.
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Background
Upper-gastrointestinal bleeding (UGIB) secondary to
peptic ulcer disease (PUD) is a serious medical condition
that is associated with substantial morbidity, high health-
care costs, and decreased quality of life [1, 2]. Patients sus-
pected to have UGIB secondary to PUD require immediate
medical attention [3]. Despite advances in management,
the risk for mortality among patients with this condition
ranges from 2.2 % upward to 14 % [4–9]. The primary risk
factors for PUD are non-steroidal anti-inflammatory drugs
(NSAIDs) and Helicobacter pylori. However, a significant
proportion of PUD is not explained by these risk factors
[10, 11]. It is important to identify other risk factors in
order to mitigate the burden associated with PUD that is
not caused by NSAIDs and Helicobacter pylori.
Epidemiologic and historical data suggest that PUD is
a relatively modern disease of industrialized nations [12].
Autopsy data showed virtually no cases of death second-
ary to PUD in the early 1800’s, but by the mid 1800’s
PUD became recognized as a major contributor to mor-
tality in Westernized nations like North America and
England [12]. Aspirin was only introduced in the early
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1900’s and thus, the epidemic rise of PUD is hypothe-
sized to have been caused by a virulent strain of Helico-
bacter pylori [12]. During the 20th century the incidence
of PUD has decreased. This is due, in part, to the identi-
fication of NSAIDs and Helicobacter pylori as the key
risk factors for PUD. However, other contributing factors
may explain the epidemiological patterns that describe
the rise and fall of PUD over the past 200 years.
Ambient air pollution contributes to the development of
a number of medical conditions [13]. Air pollution has
been associated with an increased risk of cardiovascular
disease (e.g. myocardial infraction) [14, 15], respiratory
disease (e.g. chronic obstructive pulmonary disease,
asthma) [16–19], stroke [20], cancer [21], and premature
mortality [22]. Recent discoveries suggest that air pollut-
ants affect the gastrointestinal tract and contribute to the
development of inflammatory bowel disease [23, 24],
appendicitis [25, 26], and non-specific abdominal pain
[27]. Furthermore, exposure to air pollutants has been
shown to affect the physiology of the gastrointestinal tract
by altering intestinal permeability, microbial composition
and diversity, and intestinal immunity, which may help
promote the development of gastric ulcers [28–31].
Finally, one study has demonstrated a correlation between
death from peptic ulcer disease and exposure to air
pollution [32].
Thus, we hypothesize that exposure to acute air pollu-
tion may be a contributing factor in the initiation of an
UGIB secondary to PUD.
Methods
Study population
Incident cases of UGIB secondary to PUD were identified
using hospital administrative databases. The province of
Alberta provides medical care services to all eligible resi-
dents, such that 99 % of the population is insured [33].
The discharge abstract databases (DAD) contain informa-
tion for all hospital discharges within the province of
Alberta. Furthermore, DAD contains high quality infor-
mation including the date of hospital admission and dis-
charge; the patient’s age, sex, and place of residence; and
up to 25 diagnostic codes classified using the International
Classifications of Diseases version 10 (ICD-10) system.
Charlson comorbidities [34] (excluding PUD) were
extracted.
We identified all adult (≥18 years) residents of Calgary
and Edmonton hospitalized with a newly diagnosed
UGIB secondary to PUD (ICD-10: K2X.0, K2X.2, K2X.4,
K2X.6, where X = 5–8) from 2004 to 2010. The ICD-10
codes for UGIB secondary to PUD were previously vali-
dated with a positive predictive value of 85.2 % and sen-
sitivity of 77.1 % [1]. We limited the analyses to patients
whose hospital stay was attributed to UGIB secondary to
PUD (i.e. UGIB secondary to PUD was coded in the
primary position in the discharge abstract). To remove
subsequent episodes of UGIB secondary to PUD,
unique personal health numbers were used to identify
multiple admissions for the same patient. A two year
washout period (i.e. no prior codes for UGIB secondary to
PUD) was used to confirm that our study population only
contains incident cases of UGIB secondary to PUD
hospitalized within the years of 2004 to 2010 within the
city of Calgary (n = 1374) and Edmonton (n = 1159).
We first tested our hypothesis using the population
residing within the city of Calgary (i.e. discovery cohort),
Alberta. Subsequently, the analysis was replicated using
the population living in Edmonton, Alberta (i.e. replication
cohort). Administrative data in both of these cities was
collected by the same agency, Alberta Health.
Air pollution and meteorological data
Environment Canada’s National Air Pollution Surveillance
Network monitors air pollutants in locations across
Canada. These monitors record hourly exposure to se-
lected air pollutants. We employed data on sulfur dioxide
(SO2), nitrogen dioxide (NO2), carbon monoxide (CO),
and ozone (O3), as well as particulate matter with aero-
dynamic diameter of ≤10 μm (PM10) and ≤2.5 μm (PM2.5).
Hourly measurements of the individual pollutants were
averaged across multiple monitors, to represent exposure
across the city for a given day.
Study design
Our study utilized a time-stratified case-crossover design
described by Schwartz [35]. This design was an adapta-
tion of Maclure’s 1991 study [36]. This study design has
been used to show a relationship between air pollution
and myocardial infarction [37], ventricular arrhythmias
[38], stroke [20], and asthma [39]. In a case-crossover
study each patient serves as both the case and the con-
trol. Cases are identified by the date of hospital admis-
sion with UGIB secondary to PUD. Pollutant levels for
each index date were matched and compared to a series
of referent dates based on a time-stratified design. In
this approach the referent dates selected were the same
days of the week within the same month and year as the
date of hospitalization. Bidirectional control sampling is
valid because the effect of the event (i.e. UGIB secondary
to PUD) does not influence air pollution levels [35].
Time stratified design adjusts for day of the week and
seasonal effects. A detailed review of the performance of
several different strategies to select control intervals
within a case-crossover design showed in simulation
models that the time-stratified approach was the best
method to select control periods [40]. The measures of
association generated from these comparisons rely on
contrasts within-individuals and therefore, the design of
the study is able to control for individual-level factors
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that are invariant (e.g. genetic factors, colonization with
Helicobacter pylori) during the month where case and
control intervals were identified.
Data analysis
Descriptive statistics comparing air pollutant levels and
patient characteristics between the two cities were gen-
erated using the χ2 or Mood’s median test. We examined
the effect of each air pollutant (SO2, NO2, CO, O3, PM10
and PM2.5) individually. Conditional logistic regression
was used to adjust for temperature and relative humidity
when modeling the effects of air pollution. Odds ratios
(OR) with 95 % confidence intervals (CI) were calculated
to examine the incidence of UGIB secondary to PUD
with each IQR increase in the pollutants. The IQRs were
based on the daily levels for each pollutant throughout
the entire study period and pooled between Calgary and
Edmonton. Exposure to air pollution was measured using
various time intervals: on the same day (0-day), previous
day (1-day lag), and averages over 3, 5, and 7 days prior to
event or referent days. In secondary post hoc analyses, we
stratified all of our analyses by age (above and below 70
years, which was the median age of our population), sex
(male versus female) and season (summer, fall, winter, and
spring). We used an alpha value of 0.05 to define statistical
significance. All statistical analyses were performed using
SAS version 9.3.
The study was approved by the Conjoint Health
Research Ethics Board at the University of Calgary.
Informed consent was waived by the ethics board because
patient data was anonymized.
Results
We identified 1374 and 1159 incident cases of UGIB
secondary to PUD in Calgary and Edmonton, respectively.
Baseline characteristics stratified by city are described in
Table 1. The proportion of perforated PUD was higher in
Edmonton (3.4 %) as compared to Calgary (2.0 %) (p <
0.05). Also, Calgary residents suffering from UGIB
secondary to PUD were less likely to have comorbidities
(40.9 %) as compared to Edmonton (55.3 %) (p < 0.001).
The median and interquartile range (IQR) for the air pol-
lutants for Calgary, Edmonton, and pooled across cities
are provided in Table 2.
Discovery cohort (Calgary)
The results found using the discovery cohort in Calgary
are reported in Table 3. Pollutant concentrations were
not associated with developing UGIB secondary to PUD
when the exposure period was on the same day or the
day prior to being hospitalized. However, the incidence
Table 1 Characteristics of hospitalized patients with UGIB secondary to PUD from 2004 to 2010
Variable Overall Calgary Edmonton P-value
Patients (%) 2523 1374 (54.5) 1149 (45.5)
Median Age in Years (IQR) 70.0 (54.0–80.0) 68.0 (53.0–80.0) 72.0 (56.0–80.0) 0.1
Sex (%) 0.9
Male 1561 (61.9) 851 (61.9) 710 (61.8)
Female 962 (38.1) 523 (38.1) 439 (38.2)
Number of Comorbidities (%) <0.001
0 1326 (52.6) 812 (59.1) 514 (44.7)
1 495 (19.6) 229 (16.7) 266 (23.2)
2 289 (11.5) 138 (10.0) 151 (13.1)
3 170 (6.7) 81 (5.9) 89 (7.8)
4 101 (4.0) 48 (3.5) 53 (4.6)
5 59 (2.3) 24 (1.8) 35 (3.1)
≥6 83 (3.3) 42 (3.1) 41 (3.6)
Season (%) 0.002
Autumn 635 (25.2) 314 (22.9) 321 (27.9)
Spring 621 (24.6) 372 (27.0) 249 (21.7)
Summer 659 (26.1) 369 (26.9) 290 (25.2)
Winter 608 (24.1) 319 (23.2) 289 (25.2)
Perforated PUD (%) 0.03
No 2456 (97.3) 1346 (98.0) 1110 (96.6)
Yes 67 (2.7) 28 (2.0) 39 (3.4)
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of UGIB secondary to PUD was inversely associated with
NO2, PM2.5, and PM10 when accounting for average
concentration over 3, 5, and/or 7 days.
Replication cohort (Edmonton)
When the analysis was repeated using the replication
cohort in Edmonton, none of the statistically significant
associations observed in Calgary were replicated (Table 3).
The only significant association between UGIB secondary
to PUD and any of the pollutants for all exposure dura-
tions was an inverse association with 5-day average PM10.
Secondary analyses
Stratifying the results by age (above versus below 70
years) (Additional file 1: Table S1), sex (Additional file 1:
Table S2), and season (Additional file 1: Table S3) did
not yield significant associations in Calgary that were
replicated in Edmonton.
Discussion
Based on emerging evidence that air pollution is associ-
ated with other gastrointestinal disorders [23–27], we
hypothesized that acute exposure to air pollution trig-
gered an UGIB secondary to PUD. Air pollutants have
been shown to increase intestinal permeability, alter the
gut microbiome, and promote inflammation, which may
contribute towards gastric or duodenal bleeding [28–31].
However, our discovery and replication cohorts did not
consistently demonstrate statistically significant associa-
tions between acute exposure to air pollutants and UGIB
secondary to PUD. Furthermore, in Calgary we identified
several statistically significant negative associations be-
tween air pollutants and UGIB secondary to PUD; how-
ever, these findings were not reproduced in our
replication cohort in the city of Edmonton. Thus, acute
exposure to air pollution does not appear to increase the
risk of developing an UGIB secondary to PUD.
In the discovery cohort from Calgary, NO2, PM2.5, and
PM10, over some lag periods were inversely associated
with UGIB secondary to PUD. The inverse association
may suggest that residual confounders may not have been
addressed in our analysis. Additionally, the inverse associ-
ation may be false positives due to multiple comparison
error. Studies evaluating the effects of acute exposure to
Table 2 Distribution of daily pollution concentrations from 2004 to 2010 and reported as median (25th–75th percentiles)
Pollutant Overall Calgary Edmonton P-value
O3 (ppb) 21.7 (15.0–28.3) 19.3 (13.3–25.7) 23.7 (17.5–30.9) 0.2
SO2 (ppb) 1.0 (0.9–1.8) 1.0 (1.0–2.0) 1.1 (0.8–1.6) <0.001
CO (ppm) 0.3 (0.2–0.4) 0.4 (0.3–0.4) 0.3 (0.2–0.4) <0.001
NO2 (ppb) 12.7 (7.6–19.0) 17.3 (13.0–23.5) 7.9 (5.6–12.1) <0.001
PM2.5 (μg/m3) 5.3 (3.5–7.7) 6.0 (4.3–8.7) 4.6 (3.1–6.6) 0.2
PM10 (μg/m3) 18.1 (13.0–27.0) 22.0 (15.0–32.0) 15.8 (12.0–21.8) <0.001
PPB parts per billion, PPM, parts per million, SO2 sulfur dioxide, NO2 nitrogen dioxide, CO carbon monoxide, O3 ozone, PM10 particulate matter with aerodynamic
diameter of ≤10 μm, PM2.5 particulate matters with aerodynamic diameter of ≤2.5 μm
Table 3 Association between exposure to air pollutants and hospitalization with UGIB secondary to PUD among patients residing in
Calgary (n = 1374) and Edmonton (n = 1149)
Time interval O3 SO2 NO2 CO PM2.5 PM10
Discovery cohort (Calgary)
0-day 1.14 (0.94–1.38) 0.92 (0.73–1.15) 0.94 (0.81–1.08) 0.95 (0.84–1.07) 0.92 (0.81–1.05) 1.01 (0.93–1.09)
1-day lag 0.85 (0.70–1.02) 1.02 (0.81–1.29) 1.01 (0.88–1.17) 1.05 (0.93–1.19) 0.93 (0.81–1.06) 0.95 (0.87–1.04)
3-day 0.95 (0.73–1.23) 0.88 (0.63–1.23) 0.92 (0.75–1.13) 0.96 (0.81–1.14) 0.85 (0.72–1.00) 0.94 (0.84–1.05)
5-day 1.07 (0.78–1.47) 0.87 (0.59–1.28) 0.68 (0.53–0.88) 0.82 (0.67–1.01) 0.75 (0.61–0.90) 0.87 (0.75–1.00)
7-day 1.06 (0.74–1.52) 0.90 (0.58–1.39) 0.67 (0.51–0.89) 0.85 (0.68–1.06) 0.78 (0.63–0.97) 0.88 (0.75–1.03)
Replication cohort (Edmonton)
0-day 0.99 (0.79–1.24) 1.01 (0.85–1.20) 1.11 (0.90–1.36) 1.05 (0.90–1.22) 1.01 (0.90–1.14) 0.97 (0.84–1.13)
1-day lag 0.94 (0.75–1.17) 0.97 (0.80–1.17) 1.05 (0.86–1.28) 1.02 (0.88–1.19) 0.98 (0.86–1.11) 0.87 (0.74–1.01)
3-day 0.95 (0.72–1.27) 0.99 (0.76–1.29) 1.02 (0.79–1.33) 1.02 (0.83–1.24) 0.94 (0.80–1.10) 0.83 (0.68–1.00)
5-day 1.06 (0.77–1.46) 0.91 (0.66–1.26) 0.88 (0.65–1.18) 0.94 (0.74–1.18) 0.88 (0.73–1.06) 0.79 (0.64–0.99)
7-day 1.06 (0.75–1.50) 0.89 (0.61–1.29) 0.82 (0.58–1.15) 0.90 (0.69–1.17) 0.86 (0.70–1.06) 0.79 (0.61–1.01)
aSO2 sulfur dioxide, NO2 nitrogen dioxide, CO carbon monoxide, O3 ozone, PM10 particulate matter with aerodynamic diameter of ≤10 μm, PM2.5 particulate
matters with aerodynamic diameter of ≤2.5 μm
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air pollution are subject to multiple comparisons bias
because the associations are often assessed with multiple
pollutants (e.g. SO2, NO2, CO, O3, PM10, and PM2.5) and
different exposure periods (e.g. same day, 1-day lag, and
cumulative day averages). Thus, the risk of observing a
statistically significant association by chance is increased.
This notion was supported by the observation that none
of the associations observed in the discovery cohort were
confirmed in the replication cohort.
The cities of Calgary and Edmonton are comparable
because they share similarities in demographics, health-
care delivery, and the administrative data was collected
by the same agency [41]. However, several differences
were observed between the cities. For example, the
median daily levels of SO2, CO, NO2 and PM10 were
significantly higher in Calgary than in Edmonton. Differ-
ences in the siting characteristics of the monitor stations
in the two cities (e.g. nearness to traffic) may also cause
the two cities to experience different amounts exposure
misclassification. Additionally, the patient characteristics
of the UGIB secondary to PUD patients differed between
cities. While patients were similar in age and sex distri-
butions, patients in Edmonton had more comorbidities
and were more likely to present with a perforation.
We carried out secondary analyses to evaluate whether
the effect of air pollution on UGIB secondary to PUD was
influenced by age, sex, and season. Overall, these stratified
analyses were consistent with our primary analyses show-
ing predominantly null associations that lacked replica-
tion. Because administrative databases lack many clinically
relevant variables, we were not able to explore differences
among other patient characteristics such as disease sever-
ity at presentation, Helicobacter pylori status, and use of
NSAIDs. While these factors are not known to be influ-
enced by air pollution exposure, we were not able to spe-
cifically evaluate PUD that was not caused by NSAIDs
and Helicobacter pylori.
Our analysis relied on an administrative healthcare data-
base to identify patients with UGIB secondary to PUD.
We used a previously validated ICD-10 case-definition of
UGIB secondary to PUD to identify cases [1]. The positive
predictive value of our case definition was 85 %, which
means that it is estimated that 15 % of our study popula-
tion did not have an UGIB secondary to PUD [1]. Mis-
classification error associated with our case-definition
may have influenced the effect on our risk estimates.
Several additional limitations of our study should be
considered. We utilized a case-crossover study, which lim-
ited the observations to acute exposures in patients who
have developed UGIB secondary to PUD. Furthermore,
we assigned air pollution exposures from city-wide mea-
surements from fixed monitoring stations that do not
capture personal or household level exposure. However,
several validation and simulation studies have supported
this approach in studying the health effects of air pollu-
tion [35, 42]. The case-crossover study design controls
for potential confounders that do not acutely vary across
time (e.g. Helicobacter pylori status). However, time-
dependent risk factors of PUD (e.g. NSAID use may vary
daily) may have not been controlled. Unfortunately, our
data sources do not track information regarding NSAID
use or Helicobacter pylori status, making us unable to
stratify by Helicobacter pylori, NSAID, or idiopathic
PUD. Also, air pollution levels in Calgary and Edmonton
are relatively low when compared to other regions in the
world. Low levels of air pollution may reduce the vari-
ability over short periods of time that are necessary to
detect health effects. However, similarly designed air pol-
lution studies conducted in Calgary and Edmonton have
consistently demonstrated significant associations for
other health states [20, 25, 26, 39]. Finally, our study was
limited to two cities in Alberta and thus, our findings
may not necessarily be generalizable to other regions
with different air pollution levels and patient profiles of
UGIB secondary to PUD.
Conclusions
Neither our discovery or replication cohort found an asso-
ciation between acute air pollution exposure and the
development of UGIB secondary to PUD. Our discovery
cohort produced inverse associations across several pollut-
ants and different exposure periods. However, these find-
ings were not observed in our replication cohort. Thus,
the findings may be due to unmeasured confounders and/
or spurious associations.
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Additional file 1: Table S1. Association between exposure to air
pollutants and hospitalization with UGIB secondary to PUD among patients
residing in Calgary and Edmonton stratified by sex. (DOCX 31 kb)
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